Co-treatment with the hsp90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and histone deacetylase inhibitor (HDI) vorinostat (suberoylanilide hydroxamic acid, SAHA): A highly active combination against human mantle cell lymphoma (MCL) cells.

被引：0

作者：

Hatter, A

Bali, P

Balasis, M

Fiskus, W

Boyapalle, S

Kumaraswamy, S

Rocha, K

Pranpat, M

Hannah, A

Sotomayor, E

Richon, V

Bhalla, K

机构：

[1] H Lee Moffit Canc Ctr & Res Inst, Tampa, FL USA

[2] Kosan Biosci Inc, Hayward, CA USA

[3] Merck & Co Inc, Boston, MA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2418

引用

页码：680A / 680A

页数：1